期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CXCR4阳性Lewis肺癌细胞耐药实验研究

Chemoresistance of CXCR4 positive cells in Lewis lung carcinoma cell line
下载PDF
导出
摘要 目的研究CXCR4阳性Lewis肺癌细胞(Lewis lung carcinoma,LLC)原发性耐药机制。方法激光共聚焦检测小鼠移植瘤组织内CXCR4阳性LLC;以CXCR4作为磁珠分选细胞的表面标志,应用CCK-8法检测CXCR4阳性和阴性LLC对顺铂的敏感性,RT-PCR检测两者ABCG2、IGF1RmRNA表达情况。结果小鼠移植瘤组织内散在分布胞膜呈红色荧光的CXCR4阳性LLC;CXCR4阳性与阴性LLC比较,具有更强的增顺铂抗拒性(P<0.05);CXCR4阳性LLC的ABCG2mRNA表达(0.5240±0.0078)明显高于CXCR4阴性LLC(0.3870±0.0066),相差显著(P<0.01);CXCR4阳性LLC的IGF1RmRNA表达(0.4209±0.0074)明显高于CXCR4阴性LLC(0.1848±0.0066),相差显著(P<0.01)。结论Lewis肺癌细胞中的CXCR4阳性亚群具有更强上调ABCG2、IGF1R表达的能力,具有顺铂抗拒性。 Objective To explore the chemoresistance mechanism of the CXCR4 positive cells in Lewis lung carcinoma cell line（LLC）. Methods CXCR4-positive LLC were observed by laser scanning confocal microscope （LSCM）. Isolated by magnetic cell sorting,CXCR4-positive and CXCR4-negative LLC were planted in 96-well plates,and cisplatin was added in a concentration gradient. CCK-8 cell viability assay was used to determine theirs chemotherapy sensitivity to cisplatin.RT-PCR was performed to analyze ABCG2 and IGF1R mRNA express in CXCR4-positive and CXCR4-negative populations. Results Red immunofluorescent staining cells scattered in LLC growing tumor tissue. The chemotherapy sensitivity to cisplatin of CXCR4-positive LLC were lower than of CXCR4-negative LLC（ P 〈0.05）.The expression of ABCG2 mRNA in CXCR4-positive LLC（0.5240±0.0078） was higher than that in CXCR4-negative LLC （0.3870±0.0066）. The expression of IGF1R mRNA in CXCR4-positive LLC（0.4209 ±0.0074）was higher than that in CXCR4-negative LLC（ 0.1848 ± 0.0066 ）. Conclusion CXCR4-positive LLC exhibite higher resistance to chemotherapeutic drugs than CXCR4-negative LLC. The drug-resistance machanism may be relate to the over expression of ABCG2 and IGF1R.
作者 辇伟奇 敖绪军 陈芳琳 陈正堂
机构地区 第三军医大学新桥医院全军肿瘤研究所 解放军第
出处 《局解手术学杂志》 2009年第6期371-373,376,共4页 Journal of Regional Anatomy and Operative Surgery
基金 国家高技术研究发展计划"863"项目(2007AA02Z129) 国家自然科学基金项目(30901790) 重庆市自然科学基金项目(2008BB5117)
关键词 LEWIS肺癌细胞 CXCR4 耐药机制 Lewis lung cancer cells CXCR4 chemoresistance mechanism
分类号 R734 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Pignon JP,Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group [J]. J Clin Oncol,2008,26( 21 ) :3552 - 3559.
  • 2Brooks KR, To K, Joshi MB, et al. Measurement of chemoresistance markers in patients with stage Ⅲ non-small cell lung cancer:a novel approach for patient selection[J]. Ann Thorac Surg,2003,76 ( 1 ) : 187 - 193.
  • 3Kvinlaug BT, Huntly BJ. Targeting cancer stem cells [ J ]. Expert Opin Ther Targets ,2007,11 (7) :915 - 927.
  • 4Hermann PC,Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer[ J]. Cell Stem Cell,2007,1 (3) :313 - 323.
  • 5Winton T, Livingston R,Johnson D,et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer[J]. N Engl J Med, 2005,352(25) :2589 -2597.
  • 6Reckamp KL, Fighn RA,Burdick MD, et al. CXCR4 expression on circulating' pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer [J]. BMC Cancer, 2009,9:213 -221.
  • 7Giulia Bertolini, Luca Roz, Paola Perego, et al. Highly tumorigenic lung cancer CD133 + cells display stem-like features and are spared by cisplatin treatment[J]. PNAS, 2009,106 (38) : 16281 - 16286.
  • 8Ho MM, Ng AV, Lam S,et al. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells [J]. Cancer Res,2007,67 (10) :4827 - 4833.
  • 9Bendall SC,Stwartm H,Menendez P,et al. IGF and FGF cooperatively establish the regulatory stem cell niche of p luripotent human cells in vitro[J]. Nature,2007,448 (7157) :1015 - 1021.
  • 10董强刚,姚明,耿沁,周瑾,闫明霞.人肺腺癌干细胞的分离及鉴定[J].肿瘤,2008,28(1):1-7. 被引量：42

二级参考文献16

  • 1SUMMER R, KOTTON D N, SUN X, et al. Side population cells and Bcrpl expression in lung [ J ]. Am J Physiol Lung Cell Mol Physiol, 2003, .285 ( 1 ) : L97-L104.
  • 2TAKADA T, SUZUKI H, GOTOH Y, et al. Regulation of the cell surface expression of human BCRP/ABCG2 by the phosphorylation state of Akt in polarized cells [ J ]. Drug Metab Disp, 2005, 33 ( 7 ) : 905-909.
  • 3LI L, NEAVES WB. Normal stem cells and cancer stem cells: The niche matters[ J]. Cancer Res, 2006, 66 (9) :4553-4557.
  • 4MIMEAULT M, HAUKE R, MEHTA PP, et al. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers[ J]. J Cell Mol Med, 2007, 11(5) :981-1011.
  • 5BOYER L A, LEE TI, COLE M F, et al. Core transcriptional regulatory circuitry in human embryonic stem ceils [ J ]. Cell, 2005, 122(6) :947-956.
  • 6PARK I K, MORRISON S J, CLARKE M F. Bmil, stem cells, and senescence regulation [ J ]. J Clin Invest, 2004,113 ( 2 ) : 175- 179.
  • 7NAMKOONG H, SHIN SM, KIM HK, et al. The bone morphogenetic protein antagonist gremlin I is overexpressed in human cancers and interacts with YWHAN protein[ J]. BMC Cancer, 2006,6 ( 3 ) :74-86.
  • 8CLARKE M F, DICK J E, EAVES C J, et al. Cancer stem cells- perspectives on current status and future direction: AACR workshop on cancer stem ceils [ J ]. Cancer Res,2006, 66 ( 19 ) :9339- 9344.
  • 9ASSOU S, CARROUR TL, TONDEUR S, et al. A meta-analysis of human embryonic stem ceils transcriptome integrated into a web- based expression atlas [ J ]. Stem Cells, 2007, 25 (4) :961-973.
  • 10BENDALL SC, STWART MH, MENENDEZ P, et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human ceils in vitro[ J]. Nature, 2007,448(7157) :1015- 1021.

共引文献41

局解手术学杂志
2009年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部